A single-blind crossover study of two non-steroidal anti-inflammatory drugs, nabumetone (1000 mg/day) and naproxen (500 mg/day) was performed in thirty patients suffering from definite or classical rheumatoid arthritis. Nabumetone significantly improved the various parameters assessed, while this was not observed with naproxen. The superiority of nabumetone over naproxen appeared for the anti-inflammatory activity (e.g. E.S.R., articular index, P.I.P. joint circumference, grip strength) as well as for the analgesic activity (patient's opinion). The clinical tolerance appeared equally good for both drugs.
Get full access to this article
View all access options for this article.
References
1.
BoyleE AFreemanP CManganF RThomsonM J (1978) Studies on the anti-inflammatory and gastric irritancy properties of [4-(6-methoxy-2-naphthyl) butan 2-one] (BRL 14777). International Congress of Inflammation, Bologna, Italy, p 103.
2.
GoudieA CGasterL MLakeA WRoseC JFreemanP CHuguesB OMillerD (1978) [4-(6-methoxy-2-naphthyl) butan-2-one] and related analogues, a novel structural class of anti-inflammatory compounds. Journal of Medicinal Chemistry, 21 (12), 1260.
3.
ManganF RBoyleE AThomsonM J (1981) BRL 14777 [4-(6-methoxy-2-naphthyl) butan-2-one]. A new anti-inflammatory agent. 15th International Congress of Rheumatology, Paris Abstract 1451.
